Markets
| Security | Price ▼ | % | Buy | Sell | Target price | Potential |
|---|---|---|---|---|---|---|
| Clovis Oncology Inc. |
€0.077
03.04.23 |
- | 0 | 0 | - | - |
| LexaGene Holdings Inc. |
€0.075
21.07.23 |
- | 0 | 0 | - | - |
| Optibiotix Health plc |
€0.074
17.12.25 |
- | 0 | 0 | - | - |
| Cutera Inc. |
€0.073
12.03.25 |
-61.420% | 0 | 0 | - | - |
| Mologen AG |
€0.071
27.11.20 |
-13.790% | 0 | 0 | - | - |
| Heat Biologics Inc. |
€0.069
14.06.24 |
-24.860% | 0 | 0 | - | - |
| Pt Tempo Scan Rp 50 |
€0.069
26.02.21 |
-0.720% | 0 | 0 | - | - |
| Kalbe Farma |
€0.068
17.12.25 |
22.520% | 0 | 0 | - | - |
| Quantum Genomics S.A. |
€0.068
24.10.24 |
11.290% | 0 | 0 | - | - |
| PhaseBio Pharmaceuticals Inc |
€0.068
24.02.23 |
- | 0 | 0 | - | - |
| BioLase Inc. |
€0.067
14.06.23 |
-5.520% | 0 | 7 | - | - |
| Bellicum Pharmaceuticals Inc. |
€0.064
05.03.24 |
-9.290% | 0 | 0 | - | - |
| Sintx Technologies Inc. |
€0.062
06.06.24 |
-16.890% | 4 | 0 | €22.98 | 36725.962% |
| Aspira Womens Health Inc. |
€0.061
09.05.25 |
28.720% | 0 | 0 | - | - |
| Melinta Therapeutics Inc. |
€0.060
21.04.20 |
- | 0 | 0 | - | - |
| Ampio Pharmaceuticals Inc. |
€0.060
07.01.23 |
- | 0 | 7 | - | - |
| Mauna Kea Tech |
€0.059
17.12.25 |
-0.340% | 0 | 0 | - | - |
| Immupharma plc |
€0.059
17.12.25 |
- | 0 | 0 | - | - |
| ContraFect Corp. |
€0.059
08.06.23 |
- | 0 | 0 | - | - |
| Resverlogix Corp |
€0.059
18.12.25 |
-4.880% | 0 | 0 | - | - |
| Port Erin Biopharma Investments Ltd |
€0.059
18.12.25 |
-12.030% | 0 | 0 | - | - |
| Advaxis Inc. |
€0.059
23.09.22 |
- | 0 | 7 | - | - |
| CytRx Corp. |
€0.056
17.05.23 |
- | 0 | 0 | - | - |
| Presbia plc |
€0.055
01.10.19 |
- | 0 | 0 | - | - |
| Sientra Inc. |
€0.054
01.03.24 |
0.940% | 0 | 0 | - | - |
| Lifespot Health Ltd |
€0.051
18.08.21 |
- | 0 | 0 | - | - |
| Alliqua BioMedical Inc |
€0.050
27.01.22 |
- | 0 | 0 | - | - |
| Zosano Pharma Corp. |
€0.050
28.10.22 |
- | 0 | 0 | - | - |
| Resonance Health Ltd |
€0.050
30.09.21 |
-8.330% | 0 | 0 | - | - |
| Carmat |
€0.049
25.09.25 |
-27.940% | 0 | 0 | - | - |